Hi there,

For nearly 30 years, Democracy Now! has reported on the silenced majority fighting to end war, authoritarianism, environmental destruction, human rights violations, immigration crackdowns, and so much more. Next Tuesday, December 2nd, is Giving NewsDay (independent media’s spin on Giving Tuesday). Thanks to a group of generous donors, donations made today through Giving NewsDay will be TRIPLED, which means your $15 gift is worth $45. Please donate today, so we can keep bringing you our hard-hitting, independent news. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Florida Executes Prisoner Using Anesthetic Untested in Executions

HeadlineAug 25, 2017

In Florida, prison officials on Thursday injected a 53-year-old condemned prisoner with a dose of an anesthetic never before used in a U.S. execution. At 6:10 p.m., Mark James Asay was strapped to a gurney and administered the drug etomidate. Witnesses say Asay twitched his legs briefly and appeared to breathe rapidly before his death was declared at 6:22 p.m. Etomidate was developed by Janssen, a division of Johnson & Johnson, and has been criticized as being unproven in executions. In response, the company said, “We do not condone the use of our medicines in lethal injections for capital punishment.” Mark James Asay was the first white man to be put to death in Florida for killing a black man since the state reinstituted the death penalty in 1979. We’ll have more on the death penalty and last night’s execution in Florida later in the broadcast.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top